Now showing items 1-4 of 4

    • Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence 

      Messas, G.; Meira-Lima, I; Turchi, M.; Franco, O.; Guindalini, C.; Castelo, A.; Laranjeira, R.; Vallada, H. (Lippincott Williams & Wilkins, 2005-09-01)
      Genetic factors play a role in the vulnerability to cocaine dependence. the reinforcing properties of cocaine are related to the dopaminergic system, and, in particular, the dopamine receptors have been linked to the reward ...

    • Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system 

      Rial, Daniel; Pamplona, Fabricio A.; Moreira, Eduardo L. G.; Moreira, Karin M. [UNIFESP]; Hipolide, Debora [UNIFESP]; Rodrigues, Diana I.; Dombrowski, Patricia A.; Da Cunha, Claudio; Agostinho, Paula; Takahashi, Reinaldo N.; Walz, Roger; Cunha, Rodrigo A.; Prediger, Rui D. (Wiley-Blackwell, 2014-08-01)
      Cellular prion protein (PrPC) is widely expressed in the brain. Although the precise role of PrPC remains uncertain, it has been proposed to be a pivotal modulator of neuroplasticity events by regulating the glutamatergic ...

    • Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission 

      Da Cunha, Claudio; Wietzikoski, Evellyn Claudia; Ferro, Marcelo Machado; Martinez, Glaucia Regina; Barbato Frazao Vital, Maria Aparecida; Hipolide, Debora [UNIFESP]; Tufik, Sergio [UNIFESP]; Canteras, Newton Sabino (Elsevier B.V., 2008-06-03)
      Rats with unilateral lesion of the substantia nigra pars compacta (SNpc) have been used as a model of Parkinson's disease. Depending on the lesion protocol and on the drug challenge, these rats rotate in opposite directions. ...

    • Prolactinemia is uncoupled from central D-2/D-3 dopamine receptor occupancy in amisulpride treated patients 

      Bressan, R. A.; Erlandsson, K.; Spencer, E. P.; Ell, P. J.; Pilowsky, L. S. (Springer, 2004-09-01)
      Atypical antipsychotic drugs are classically associated with lower propensity to extrapyramidal symptoms (EPS) and hyperprolactinemia than typical antipsychotic drugs. It has not been clarified why some atypical antipsychotic ...